期刊文献+

淫羊藿不同提取物对去势大鼠PINP、NTx影响的实验研究 被引量:5

Experimental study of the effect of different extracts of epimedium on PINP and NTx in ovariectomized rats
下载PDF
导出
摘要 目的通过PINP、NTx指标的变化研究淫羊藿抗骨质疏松的作用机制。方法采用去卵巢方法诱发大鼠骨质疏松模型,淫羊藿不同提取物进行灌胃,检测PINP、NTx等相关指标的变化,评价淫羊藿抗骨质疏松的疗效。结果与空白对照组相比,模型组E2、PINP含量明显降低(P<0.001),NTx水平升高(P<0.001);与模型组比较,淫羊藿不同提取物各剂量组均可提高去势大鼠E2水平(P<0.05),提高PINP水平(P<0.05),降低NTx水平(P<0.05);淫羊藿水煎液各组PINP和NTx含量高于其他各组,差异具有统计学意义。结论淫羊藿具有雌激素样作用,淫羊藿不同提取物均可改善去势大鼠骨质疏松症。 Objective Through the observation of changes of PINP and NTx, to study the anti-osteoporosis mechanism of epimedium. Methods The osteoporosis rat model was established using ovariectomy. Rats were gavaged with different extracts of epimedium. Then, the changes of PINP, NTx, and other related indexes were detected, in order to evaluate the efficacy of epimedium on anti-osteoporosis. Results Compared with that in the control group, the contents of E2 and PINP in model group decreased significantly ( P 〈 0. 001 ), while the levels of NTx elevated ( P 〈 0. 001 ). Compared with that in model group, the levels of E2 in ovariectomized rats in groups with different dosage of the extracts of epimedium improved significantly ( P 〈 0.05 ), the levels of PINP also increased (P 〈 0.05), while the levels of NTx reduced ( P 〈 0. 05 ). The content of PINP and NTx in groups with epimedium decoction was higher than that in the other groups, and the difference was statistically significant. Conclusion Epimedium has estrogen-like effect. Different extracts of epimedium can improve osteoporosis in ovariectomized rats.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2014年第2期142-144,188,共4页 Chinese Journal of Osteoporosis
基金 2010年甘肃省自然科学研究基金计划(1010RJZA160)
关键词 淫羊藿 淫羊藿苷 淫羊藿总黄酮 PINP NTX Epimedium Icariin Epimedium flavonoids PINP NTx
  • 相关文献

参考文献5

二级参考文献33

  • 1周丽珍,向青,刘忠厚.合理使用骨质疏松症诊疗的骨代谢标志物指南(2004年版)[J].中国骨质疏松杂志,2004,10(4):397-404. 被引量:21
  • 2程晓光.骨密度测量和骨质疏松诊断[J].国外医学(内分泌学分册),2005,25(5):308-310. 被引量:33
  • 3张瑾,邓敬兰,欧阳巧洪,刘加昌,韩翠华,刘青.原发性骨质疏松症患者骨密度和骨代谢指标的对比研究[J].中国骨质疏松杂志,2005,11(3):319-320. 被引量:21
  • 4吕晓芳,于世英,冷彦.骨代谢生化指标在恶性肿瘤骨转移诊断中的价值[J].中国肿瘤临床,2007,34(3):154-156. 被引量:12
  • 5Pisetsky DS. The immune response to cell death in SLE. Autoimmun Rev, 2004,3 ( 8 ) : 500-504.
  • 6Poli V, Balena R, Farrori E,et al. EMBO J, 1994,13 (5) 1189-1196.
  • 7Vlimki MJ, Farrerons Minguella J, Halse J, et al. Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, doubleblind, placebo-controlled, parallel-group, phase Ⅲ trial [J]. Clin Ther,2007,29(9) : 1937-1949.
  • 8Downs RW Jr, Moffett AM, Ghosh A, et al. Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass[J]. Osteo poros Int,2009,20(10) :834-836.
  • 9Lumachi F, Ermani M, Camozzi V, et al. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis [J]. Ann N Y Acad Sci,2009,10(7):1173-1174.
  • 10Hari-Kumar KV, Muthukrishnan J, Verma A, et al. Correlation between bone markers and bone mineral density in postmenopausal women with osteoporosis[J]. Endocr Pract,2008,14(9) : 1102-1107.

共引文献53

同被引文献61

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部